Weekly GLP-1 receptor agonist that quietens appetite and steadies blood sugar.
Typical dose range: 0.25–2.4 mg
Frequency: Weekly
Route: Subcutaneous
Half-life: ~7 days
Evidence level: Strong (FDA-approved)
Long-acting GLP-1 analogue best known under the Ozempic and Wegovy brands. Members typically titrate slowly from 0.25 mg to a maintenance dose, holding at the lowest effective level to manage GI side effects.